Scan to Download
The broader indices outperformed their larger peers with MidCap index rising 0.5% and SmallCap adding 0.7%. Ten of the 19 sectoral indices compiled by BSE Ltd. decllined with power index losing over 2%. On the flipside, the realty measure gained over 2% while metal index jumped nearly 2%.
The market breadth was skewed in the favour of bulls. About 1,761 stocks rose, 1,593 fell and 123 remained unchanged.
Tech Giants Accuse India Agency of Ignorance in Xiaomi Spat
NARCL appoints Natarajan Sundar as MD & CEO, with effect from Monday.
Sundar retired as chief credit officer at State Bank of India on April 30.
Previous incumbent Padmakumar Nair, who was deputed from SBI, has returned to the bank.
Last week, NARCL board appointed Karnam Sekar as non-executive chairman and independent director
Former RBI Executive Director Malvika Sinha will also join as independent director on the board
Source: NARCL statement
Shares of books and atlas publisher MPS Ltd rose over 7%, the most in two weeks.
The rise comes after the company completed the acquisition of EI Designs through its susbsidiary MPS Interactive Systems for Rs 40 crore, on May 29.
EI Designs is involved in eLearning industry and reported a revenue of Rs 31.71 crore in FY2020-21.
The acquisition is expected to add to operational efficiency gains for MPS Interactive.
Trading volume is nearly five times the 30-day average.
Source: Exchange filing, Bloomberg
An Early and Likely Normal Monsoon Boosts India’s Crop Outlook
The Sensex fell 0.4% to 55,708.69. The 30-stock gauge lost nearly 540 points to an intraday low of 55,386.50. The Nifty 50 also declined by similar magnitude to 16,618.95.
The broader indices outperformed their larger peers, with S&P BSE Midcap gaining 0.5% and SmallCap adding 0.78%. Ten of the 19 sectoral indices compiled by BSE Ltd. declined with Consumer Durables index losing 1%. On the flipside, the realty and metal indices rise over 1.4%.
The market breadth is skewed in the favour of bulls. About 1,815 stocks advanced, 1,392 declined and 135 remained unchanged.
Indraprastha Gas has appointed Sanjay Kumar, currently Head (Finance) as Chief Financial Officer with effect from tomorrow, June 1.
The incumbent CFO Bimal Ram Nagar shall cease as CFO of the company from tomorrow.
Source: Exchange filing
Shares of Life Insurance Corporation of India fell 3.31%, the steepest decline in nearly two weeks since May 19.
The company reported its Q4 numbers post market hours on Monday.
Revenue up 12% at Rs 2,12,230 crore Vs 1,90,099 crore
EBITDA at Rs 2,396 crore Vs Rs 2,921 crore, down 18%
EBITDA margins at 1.13% vs 1.54%
Net profit down 17% of Rs 2,409 crore Vs Rs 2,917 crore
EPS at Rs 3.81 vs Rs 4.61
Recommended dividend of Rs 1.5 per share of face value Rs 10 each
LIC said that it is still in the process of determining its Indian Embedded Value for the year ended March.
Source: Exchange filing, Bloomberg
The S&P BSE Sensex fell 0.67% to 55,552.71. The NSE Nifty 50 declined by similar magnitude to 16,569.80.
The broader indices outperformed their larger peers, losing 0.1%. Twelve of the 19 sectoral indices compiled by BSE Ltd. declined with S&P BSE Information Technology index losing over 1.25%.
The market breadth was skewed slightly in the favour of bulls. About 1,188 stocks advanced, 1,077 declined and 87 remained unchanged.
Mahindra & Mahindra: The company sold 2.76% stake in TVS Automobile Solutions for Rs 45 crore.
MPS: The company completed acquisition of EI Designs through MPS Interactive Systems, its wholly owned subsidiary for Rs 40 crore.
Lemon Tree Hotels: The company has signed a license agreement for a 40 room hotel at Chirang, Assam under its brand ‘Keys Select, by Lemon Tree Hotels.’ The hotel is expected to be operational by June, 2026.
LIC Q4 FY22 (Consolidated, YoY)
Revenue up 12% at Rs 2,12,230 crore Vs 1,90,099 crore
EBITDA at Rs 2,396 crore Vs Rs 2,921 crore, down 18%
EBITDA margins at 1.13% vs 1.54%
Net profit down 17% of Rs 2,409 crore Vs Rs 2,917 crore
EPS at Rs 3.81 vs Rs 4.61
Recommended dividend of Rs 1.5 per share of face value Rs 10 each
Sun Pharmaceuticals Q4 FY22 (Consolidated, YoY)
Revenue up 11% at Rs 9,447 crore Vs Rs 8,523 crore (Bloomberg estimate: Rs 9,576 crore)
EBITDA up 6% to Rs 2,179 crore from Rs 2,059 crore (Bloomberg estimate: Rs 2,544 crore)
EBITDA margins at 23.1% Vs 24.2% (Bloomberg estimate: 26.6%)
Net loss of Rs 2,277 crore Vs net profit of Rs 894 crore (Bloomberg estimate: Rs 1,707 crore Profit)
Recommended final dividend of Rs 3 per share of face value Re 1 each
Approved merger of its wholly owned subsidiaries Sun Pharmaceutical Medicare, Green Eco Development Centre, Faststone Mercantile, Realstone Multitrade and Skisen Labs with the company.
Aurobindo Pharma Q4 FY22 (Consolidated, YoY)
Revenue down 3% at Rs 5,809 crore Vs Rs 6,002 crore (Bloomberg estimate: Rs 5,901 crore)
EBITDA down 24% to Rs 974 crore from Rs 1,275 crore (Bloomberg estimate: Rs 1,029 crore)
EBITDA margins at 16.8% Vs 21.2% (Bloomberg estimate: 17.4%)
Net profit down 28% to Rs 576 crore Vs Rs 802 crore (Bloomberg estimate: Rs 600 crore)
Approved fourth interim dividend of Rs 4.5 per share of face value of Rs 1 each
Jindal Steel and Power Q4 FY22 (Consolidated, YoY)
Revenue up 35% at Rs 14,339.49 crore Vs Rs 10,593.72 crore (Bloomberg estimate: Rs 14,900.9 crore)
EBITDA fell 38% at Rs 3,070.2 crore Vs Rs 4,963.61 crore (Bloomberg estimate: Rs 3,854.4 crore)
EBITDA margin 21.41% Vs 46.85% (Bloomberg estimate: 25.86%)
Net profit up 3% at Rs 2,206.97 crore Vs Rs 2,139.28 crore (Bloomberg estimate: Rs 1,999.8 crore)
Recommended final dividend of Rs 2 per share of face value of Re 1.
IRCTC Q4 FY22 (Consolidated, QoQ)
Revenue up 28% at Rs 690.96 crore Vs Rs 540.21 crore
EBITDA fell 2% at Rs 264.35 crore Vs Rs 268.98 crore
EBITDA margin 38.3% Vs 49.8%
Net profit up 2% at Rs 213.78 crore Vs Rs 208.8 crore
Recommended final dividend of Rs 1.5 per share of face value of Rs 2 each
Trident Q4 FY22 (Consolidated, YoY)
Revenue up 37% at Rs 1,847.14 crore Vs Rs 1,350 crore
EBITDA up 40% at Rs 327.57 crore Vs Rs 235.56 crore
EBITDA margin 17.73% Vs 17.45%
Net profit up 130% at Rs 173.55 crore Vs Rs 75.63 crore
Dilip Buildcon Q4 FY22 (Consolidated, YoY)
Revenue fell 15% at Rs 2,663.7 crore Vs Rs 3,135.47 crore
EBITDA fell 62.5% at Rs 218.63 crore Vs Rs 584.33 crore
EBITDA margin 8.21% Vs 18.64%
Net loss up 58% at Rs 41.09 crore Vs Rs 96.9 crore
Appointed Sanjay Kumar Bansal as the Chief Financial Officer with effect from May 31.
Rail Vikas Nigam Q4 FY22 (Consolidated, YoY)
Revenue up 15% at Rs 6,437.54 crore Vs Rs 5,577.92 crore
EBITDA up 15% at Rs 408.38 crore Vs Rs 354.07 crore
EBITDA margin 6.34% Vs 6.35%
Net profit fell 1% at Rs 378.16 crore Vs Rs 381.79 crore
Delhivery Q4 FY22 (Consolidated, QoQ)
Revenue up 4% at Rs 2,071.75 crore Vs Rs 1,995.04 crore
EBIT fell 20% at negative Rs 159.32 crore Vs negative Rs 132.38 crore
EBIT margin -7.69% Vs -6.64%
Net loss fell 5% at Rs 119.86 crore Vs Rs 126.51 crore
NBCC (India) Q4 FY22 (Consolidated, YoY)
Revenue fell 11% at Rs 2,441.04 crore Vs Rs 2,752.63 crore
EBITDA fell 8.5% at Rs 72.98 crore Vs Rs 79.7 crore
EBITDA margin 3% Vs 2.9%
Net profit fell 57% at Rs 35.38 crore Vs Rs 82.36 crore
NLC India Q4 FY22 (Consolidated, YoY)
Revenue up 9% at Rs 3,085.89 crore Vs Rs 2,839.55 crore
EBITDA up 26.5% at Rs 1,068.74 crore Vs Rs 845.13 crore
EBITDA margin 34.6% Vs 29.7%
Net profit fell 54% at Rs 331.16 crore Vs Rs 725.5 crore
Radico Khaitan Q4 FY22 (Consolidated, YoY)
Revenue up 9.5% at Rs 3,224.45 crore Vs Rs 2,946.43 crore
EBITDA fell 21.5% at Rs 79.61 crore Vs Rs 101.35 crore
EBITDA margin 2.5% Vs 3.4%
Net profit fell 32% at Rs 50.15 crore Vs Rs 73.53 crore
Recommended final dividend of Rs 3 per share of face value of Rs 2 each
Dish TV India Q4 FY22 (Consolidated, QoQ)
Revenue fell 10% at Rs 642.7 crore Vs Rs 710.67 crore
EBIT fell 37% at Rs 114.95 crore Vs Rs 181.92 crore
EBIT margin 17.9% Vs 25.6%
Net loss of Rs 2,032 crore Vs net profit of 8,021 crore. Loss includes impairment of assets of Rs 2,653.88 crore. Profit before exceptional items and tax stood at Rs 41.82 crore
Campus Activewear Q4 FY22 (Consolidated, YoY)
Revenue up 28% at Rs 352.33 crore Vs Rs 275.1 crore
EBITDA up 21% at Rs 78.40 crore Vs Rs 65.03 crore
EBITDA margin 22.25% Vs 23.64%
Net profit up 296% at Rs 39.6 crore Vs Rs 10 crore
Medplus Health Services Q4 FY22 (Consolidated, QoQ)
Revenue up 3.5% at Rs 965.9 crore Vs Rs 933.45 crore
EBIT fell 21% at Rs 50.36 crore Vs Rs 63.43 crore
EBIT margin 5.21% Vs 6.8%
Net profit fell 32% at Rs 11.43 crore Vs Rs 16.91 crore
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
